Xeris Biopharma Holdings, Inc. (XERS:NASDAQ) closed at $16.66 on November 13, 2026, up 0.06% on the day. The stock trades 1.3% below its 52-week high of $16.88 and 217.3% above its 52-week low of $5.25. Over the past year, it gained 132.0%. Xeris Biopharma Holdings, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 13, 2025, XERS closed higher on 132 days (52%). Its best day was November 5, 2026 (+25.05%) and its worst was August 6, 2026 (-9.25%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.
Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.
Find more stocks like XERS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.